Related Experiment Video
Updated: Sep 15, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Novel risk prediction model for major adverse cardiovascular events in minimally invasive mitral valve surgery: a
Hongye Bai1,2, Jingwei Zhang2, Yi Xu2
1Department of Thoracic and Cardiovascular Surgery, Capital Medical University, Beijing, China.
Background:
Minimally invasive mitral valve surgery (MIMVS) has become the standard procedure for treating mitral valve pathologies. However, the existing cardiac risk model fails to consider the distinctive perfusion and ventilation techniques of MIMVS, leading to inaccurate prediction of perioperative risks. This study aimed to identify the perioperative risk factors for major adverse cardiovascular events (MACEs) in MIMVS and develop a predictive model based on these factors.
Methods:
This single-center retrospective study recruited 480 patients undergoing MIMVS at Beijing Anzhen Hospital between April 2010 and May 2024 and collected data on 79 perioperative clinical variables. The primary outcome was MACE within 30 days postoperatively. Univariate Cox regression analysis was used to analyze the associations between variables and outcomes, whereas elastic net regression was used to develop a risk prediction model (CompliMit Score) for MACE. The model was validated using 200 bootstrap replicates.
Results:
The 30-day MACE rate was 12%, and 31 clinical variables significantly correlated with MACE: 13 preoperatively, 9 intraoperatively, and 9 postoperatively. From these, we developed the CompliMit Score, which included 14 risk factors identified through elastic net regression. The CompliMit Score identified more high-risk patients for MACE than the European System for Cardiac Operative Risk Evaluation II {area under the curve: 0.92 [95% confidence interval (CI): 0.88-0.96] vs. 0.67 (95% CI: 0.59-0.75)}, and internal validation confirmed its superior predictive performance.
Conclusions:
Factors influencing MIMVS prognosis included preoperative, intraoperative, and postoperative variables. The newly developed CompliMit Score effectively identified patients who are at high risk of perioperative MACE, thus facilitating targeted postoperative care and resource allocation.
Insights
Minimally invasive mitral valve surgery (MIMVS) requires a new risk model. The CompliMit Score accurately predicts major adverse cardiovascular events (MACE) in MIMVS patients, outperforming existing tools.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Medical Technology
Background:
- Minimally invasive mitral valve surgery (MIMVS) is standard for mitral valve pathologies.
- Current cardiac risk models inadequately assess MIMVS-specific perfusion and ventilation techniques.
- This leads to imprecise prediction of perioperative risks.
Purpose of the Study:
- Identify perioperative risk factors for major adverse cardiovascular events (MACE) in MIMVS.
- Develop and validate a novel predictive model for MACE in MIMVS patients.
Main Methods:
- Retrospective study of 480 MIMVS patients.
- Collected data on 79 perioperative clinical variables.
- Developed the CompliMit Score using elastic net regression and validated with bootstrap replicates.
Main Results:
- The 30-day MACE rate was 12%.
- 31 clinical variables (pre-, intra-, and postoperative) correlated with MACE.
- The CompliMit Score (14 risk factors) demonstrated superior MACE prediction (AUC 0.92) compared to EuroSCORE II (AUC 0.67).
Conclusions:
- Preoperative, intraoperative, and postoperative factors influence MIMVS prognosis.
- The CompliMit Score effectively identifies high-risk patients for perioperative MACE.
- This facilitates targeted postoperative care and optimized resource allocation.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse III: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction

